Medline Jumps as Analysts Turn Bullish After 2025’s Biggest IPO
Medline Inc. shares advanced Monday as Wall Street analysts struck a bullish tone on the medical supplier’s business model and growth prospects following its $7.2 billion IPO last month.
By Natalia Kniazhevich · Bloomberg
Medline Inc. shares advanced Monday as Wall Street analysts struck a bullish tone on the medical supplier’s business model and growth prospects following its $7.2 billion IPO last month.